Stocks and Investing
Stocks and Investing
Fri, November 10, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Oren Livnat Maintained (TARS) at Strong Buy with Increased Target to $50 on, Nov 10th, 2023
Oren Livnat of HC Wainwright & Co., Maintained "Tarsus Pharmaceuticals, Inc." (TARS) at Strong Buy with Increased Target from $42 to $50 on, Nov 10th, 2023.
Oren has made no other calls on TARS in the last 4 months.
There is 1 other peer that has a rating on TARS. Out of the 1 peers that are also analyzing TARS, 0 agree with Oren's Rating of Hold.
This is the rating of the analyst that currently disagrees with Oren
- Eddie Hickman of "Guggenheim" Maintained at Strong Buy with Increased Target to $49 on, Monday, September 11th, 2023
Contributing Sources